{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T02:08:18Z","timestamp":1780106898679,"version":"3.54.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.omtn.2025.102788","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:35:52Z","timestamp":1765326952000},"page":"102788","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["AAV2-mediated intravitreal delivery of exon-specific U1 snRNA rescues optic neuropathy in familial dysautonomia"],"prefix":"10.1016","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0652-2630","authenticated-orcid":false,"given":"Anil","family":"Chekuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnakanth","family":"Kondabolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily G.","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swanand","family":"Koli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Chagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drenushe","family":"Krasniqi-Vanmeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max E.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Bolduc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Pagani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luk H.","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1658-5213","authenticated-orcid":false,"given":"Elisabetta","family":"Morini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7958-6494","authenticated-orcid":false,"given":"Susan A.","family":"Slaugenhaupt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2025.102788_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0065-3101(22)00845-3","article-title":"Familial dysautonomia: diagnosis, pathogenesis and management","volume":"21","author":"Axelrod","year":"1974","journal-title":"Adv. Pediatr."},{"key":"10.1016\/j.omtn.2025.102788_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0165-1838(79)90010-9","article-title":"Familial dysautonomia (a brief review)","volume":"1","author":"Pearson","year":"1979","journal-title":"J. Auton. Nerv. Syst."},{"key":"10.1016\/j.omtn.2025.102788_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0022-510X(78)90187-9","article-title":"Quantitative studies of sympathetic ganglia and spinal cord intermedio-lateral gray columns in familial dysautonomia","volume":"39","author":"Pearson","year":"1978","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.omtn.2025.102788_bib4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00005792-197009000-00001","article-title":"Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature","volume":"49","author":"Brunt","year":"1970","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.omtn.2025.102788_bib5","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1517\/14656566.6.4.561","article-title":"Familial dysautonomia: a review of the current pharmacological treatments","volume":"6","author":"Axelrod","year":"2005","journal-title":"Expet Opin. Pharmacother."},{"key":"10.1016\/j.omtn.2025.102788_bib6","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1089\/109065703322146830","article-title":"Screening for familial dysautonomia in Israel: evidence for higher carrier rate among Polish Ashkenazi Jews","volume":"7","author":"Lehavi","year":"2003","journal-title":"Genet. Test."},{"key":"10.1016\/j.omtn.2025.102788_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/qjmed\/hci128","article-title":"Drugs for exceptionally rare diseases: do they deserve special status for funding?","volume":"98","author":"Hughes","year":"2005","journal-title":"QJM"},{"key":"10.1016\/j.omtn.2025.102788_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/jnen\/nlw118","article-title":"Pathological Confirmation of Optic Neuropathy in Familial Dysautonomia","volume":"76","author":"Mendoza-Santiesteban","year":"2017","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.omtn.2025.102788_bib9","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/WNO.0b013e318230feab","article-title":"Clinical neuro-ophthalmic findings in familial dysautonomia","volume":"32","author":"Mendoza-Santiesteban","year":"2012","journal-title":"J. Neuro Ophthalmol."},{"key":"10.1016\/j.omtn.2025.102788_bib10","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1007\/s00415-014-7258-2","article-title":"Selective retinal ganglion cell loss in familial dysautonomia","volume":"261","author":"Mendoza-Santiesteban","year":"2014","journal-title":"J. Neurol."},{"key":"10.1016\/j.omtn.2025.102788_bib11","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00415-020-10298-4","article-title":"Longitudinal changes in the macula and optic nerve in familial dysautonomia","volume":"268","author":"Kfir","year":"2021","journal-title":"J. Neurol."},{"key":"10.1016\/j.omtn.2025.102788_bib12","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1261\/rna.7247705","article-title":"An early step in wobble uridine tRNA modification requires the Elongator complex","volume":"11","author":"Huang","year":"2005","journal-title":"RNA"},{"key":"10.1016\/j.omtn.2025.102788_bib13","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S1097-2765(00)80179-3","article-title":"Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation","volume":"3","author":"Otero","year":"1999","journal-title":"Mol. Cell"},{"key":"10.1016\/j.omtn.2025.102788_bib14","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/cr.2016.112","article-title":"Elongator controls cortical interneuron migration by regulating actomyosin dynamics","volume":"26","author":"Tielens","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.omtn.2025.102788_bib15","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/hmg\/ddab359","article-title":"Selective retinal ganglion cell loss and optic neuropathy in a humanized mouse model of familial dysautonomia","volume":"31","author":"Chekuri","year":"2022","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib16","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/hmg\/ddv634","article-title":"Sensory and autonomic deficits in a new humanized mouse model of familial dysautonomia","volume":"25","author":"Morini","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib17","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ajhg.2023.01.019","article-title":"Development of an oral treatment that rescues gait ataxia and retinal degeneration in a phenotypic mouse model of familial dysautonomia","volume":"110","author":"Morini","year":"2023","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.ajhg.2019.02.009","article-title":"ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia","volume":"104","author":"Morini","year":"2019","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib19","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1093\/hmg\/ddy151","article-title":"Exon-specific U1 snRNAs improve ELP1 exon 20 definition and rescue ELP1 protein expression in a familial dysautonomia mouse model","volume":"27","author":"Donadon","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib20","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1203\/PDR.0b013e31822e1825","article-title":"Kinetin improves IKBKAP mRNA splicing in patients with familial dysautonomia","volume":"70","author":"Axelrod","year":"2011","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.omtn.2025.102788_bib21","doi-asserted-by":"crossref","first-page":"4833","DOI":"10.1093\/nar\/gky249","article-title":"Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice","volume":"46","author":"Sinha","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2025.102788_bib22","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1016\/j.ajhg.2022.07.004","article-title":"Rescue of a familial dysautonomia mouse model by AAV9-Exon-specific U1 snRNA","volume":"109","author":"Romano","year":"2022","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11168","article-title":"Therapeutic activity of modified U1 core spliceosomal particles","volume":"7","author":"Rogalska","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102788_bib24","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/jth.12471","article-title":"An engineered U1 small nuclear RNA rescues splicing defective coagulation F7 gene expression in mice","volume":"12","author":"Balestra","year":"2014","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.omtn.2025.102788_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/mtna.2016.77","article-title":"An Exon-Specific U1snRNA Induces a Robust Factor IX Activity in Mice Expressing Multiple Human FIX Splicing Mutants","volume":"5","author":"Balestra","year":"2016","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"10.1016\/j.omtn.2025.102788_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1006082","article-title":"Molecular Basis and Therapeutic Strategies to Rescue Factor IX Variants That Affect Splicing and Protein Function","volume":"12","author":"Tajnik","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib27","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1093\/hmg\/dds045","article-title":"An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects","volume":"21","author":"Fernandez Alanis","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib28","doi-asserted-by":"crossref","first-page":"6461","DOI":"10.1182\/blood-2009-03-207613","article-title":"Rescue of coagulation factor VII function by the U1+5A snRNA","volume":"113","author":"Pinotti","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102788_bib29","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1182\/blood-2007-10-117440","article-title":"U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency","volume":"111","author":"Pinotti","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.omtn.2025.102788_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ajhg.2014.12.009","article-title":"Improvement of SMN2 pre-mRNA processing mediated by exon-specific U1 small nuclear RNA","volume":"96","author":"Dal Mas","year":"2015","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/srep11746","article-title":"Spinal muscular atrophy phenotype is ameliorated in human motor neurons by SMN increase via different novel RNA therapeutic approaches","volume":"5","author":"Nizzardo","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.omtn.2025.102788_bib32","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1038\/s41467-021-23663-2","article-title":"A deep learning approach to identify gene targets of a therapeutic for human splicing disorders","volume":"12","author":"Gao","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtn.2025.102788_bib33","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1089\/hum.2012.110","article-title":"A gene therapeutic approach to correct splice defects with modified U1 and U6 snRNPs","volume":"24","author":"Schmid","year":"2013","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib34","doi-asserted-by":"crossref","first-page":"5078","DOI":"10.1093\/hmg\/dds354","article-title":"IKAP expression levels modulate disease severity in a mouse model of familial dysautonomia","volume":"21","author":"Dietrich","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtn.2025.102788_bib35","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygeno.2007.05.012","article-title":"A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect","volume":"90","author":"Hims","year":"2007","journal-title":"Genomics"},{"key":"10.1016\/j.omtn.2025.102788_bib36","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1177\/2472555218792264","article-title":"Development of a Screening Platform to Identify Small Molecules That Modify ELP1 Pre-mRNA Splicing in Familial Dysautonomia","volume":"24","author":"Salani","year":"2019","journal-title":"SLAS Discov."},{"key":"10.1016\/j.omtn.2025.102788_bib37","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00109-006-0137-2","article-title":"Therapeutic potential and mechanism of kinetin as a treatment for the human splicing disease familial dysautonomia","volume":"85","author":"Hims","year":"2007","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.omtn.2025.102788_bib38","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S0140-6736(16)30371-3","article-title":"Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial","volume":"388","author":"Bennett","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2025.102788_bib39","doi-asserted-by":"crossref","first-page":"7739","DOI":"10.1167\/iovs.14-15388","article-title":"LHON gene therapy vector prevents visual loss and optic neuropathy induced by G11778A mutant mitochondrial DNA: biodistribution and toxicology profile","volume":"55","author":"Koilkonda","year":"2014","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2025.102788_bib40","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib41","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.ophtha.2017.05.016","article-title":"Gene Therapy for Leber Hereditary Optic Neuropathy: Low- and Medium-Dose Visual Results","volume":"124","author":"Guy","year":"2017","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2025.102788_bib42","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10633-007-9059-8","article-title":"The mouse pattern electroretinogram","volume":"115","author":"Porciatti","year":"2007","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.omtn.2025.102788_bib43","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1167\/iovs.06-0733","article-title":"The pattern electroretinogram as a tool to monitor progressive retinal ganglion cell dysfunction in the DBA\/2J mouse model of glaucoma","volume":"48","author":"Porciatti","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.omtn.2025.102788_bib44","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0143-16.2016","article-title":"Loss of Ikbkap Causes Slow, Progressive Retinal Degeneration in a Mouse Model of Familial Dysautonomia","volume":"3","author":"Ueki","year":"2016","journal-title":"eNeuro"},{"key":"10.1016\/j.omtn.2025.102788_bib45","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033746","article-title":"Retina-specific loss of Ikbkap\/Elp1 causes mitochondrial dysfunction that leads to selective retinal ganglion cell degeneration in a mouse model of familial dysautonomia","volume":"11","author":"Ueki","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtn.2025.102788_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000526317","article-title":"Gene Therapy for Inherited Retinal Disease: Long-Term Durability of Effect","volume":"66","author":"Leroy","year":"2023","journal-title":"Ophthalmic Res."},{"key":"10.1016\/j.omtn.2025.102788_bib47","article-title":"Reduction of retinal ganglion cell death in mouse models of familial dysautonomia using AAV-mediated gene therapy and splicing modulators","author":"Schultz","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.omtn.2025.102788_bib48","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1038\/mt.2010.274","article-title":"Long-term safety and efficacy following systemic administration of a self-complementary AAV vector encoding human FIX pseudotyped with serotype 5 and 8 capsid proteins","volume":"19","author":"Nathwani","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib49","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1089\/hum.2020.138","article-title":"Adeno-Associated Virus-Based Gene Therapy for Lifelong Correction of Genetic Disease","volume":"31","author":"Brommel","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib50","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.omtm.2017.11.007","article-title":"Emerging Issues in AAV-Mediated In Vivo Gene Therapy","volume":"8","author":"Colella","year":"2018","journal-title":"Mol. Ther., Methods Clin. Dev."},{"key":"10.1016\/j.omtn.2025.102788_bib51","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0002-9394(89)90221-3","article-title":"Intraocular pressure and glaucoma","volume":"107","author":"Sommer","year":"1989","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.omtn.2025.102788_bib52","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1442-9071.2012.02770.x","article-title":"'Structure-function relationship' in glaucoma: past thinking and current concepts","volume":"40","author":"Malik","year":"2012","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.omtn.2025.102788_bib53","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002103","article-title":"Dosage thresholds for AAV2 and AAV8 photoreceptor gene therapy in monkey","volume":"3","author":"Vandenberghe","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.omtn.2025.102788_bib54","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1167\/tvst.12.11.24","article-title":"Safety and Efficacy of Adeno-Associated Viral Gene Therapy in Patients With Retinal Degeneration: A Systematic Review and Meta-Analysis","volume":"12","author":"Sobh","year":"2023","journal-title":"Transl. Vis. Sci. Technol."},{"key":"10.1016\/j.omtn.2025.102788_bib55","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMoa1414221","article-title":"Long-term effect of gene therapy on Leber's congenital amaurosis","volume":"372","author":"Bainbridge","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.omtn.2025.102788_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.preteyeres.2020.100915","article-title":"Immune responses to retinal gene therapy using adeno-associated viral vectors - Implications for treatment success and safety","volume":"83","author":"Bucher","year":"2021","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.omtn.2025.102788_bib57","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/mt.2010.234","article-title":"Novel properties of tyrosine-mutant AAV2 vectors in the mouse retina","volume":"19","author":"Petrs-Silva","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib58","doi-asserted-by":"crossref","first-page":"8936","DOI":"10.1523\/JNEUROSCI.18-21-08936.1998","article-title":"The major cell populations of the mouse retina","volume":"18","author":"Jeon","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.omtn.2025.102788_bib59","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ophtha.2015.10.025","article-title":"Gene Therapy for Leber Hereditary Optic Neuropathy: Initial Results","volume":"123","author":"Feuer","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.omtn.2025.102788_bib60","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1038\/gt.2015.69","article-title":"Prediction of adeno-associated virus neutralizing antibody activity for clinical application","volume":"22","author":"Wang","year":"2015","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib61","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ymthe.2019.12.010","article-title":"AAV Vector Immunogenicity in Humans: A Long Journey to Successful Gene Transfer","volume":"28","author":"Costa Verdera","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib62","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jtha.2023.03.043","article-title":"Multidisciplinary approach for gene therapy-related hepatotoxicity","volume":"21","author":"Jagadisan","year":"2023","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.omtn.2025.102788_bib63","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1016\/j.jhep.2023.03.021","article-title":"Multidisciplinary approach and reactive immunosuppression for gene therapy-related hepatotoxicity","volume":"79","author":"Jagadisan","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102788_bib64","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhep.2020.11.001","article-title":"Hepatotoxicity following administration of onasemnogene abeparvovec (AVXS-101) for the treatment of spinal muscular atrophy","volume":"74","author":"Chand","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omtn.2025.102788_bib65","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1089\/hum.2020.167","article-title":"Adeno-Associated Virus-Induced Dorsal Root Ganglion Pathology","volume":"31","author":"Hordeaux","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib66","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41434-023-00419-9","article-title":"The estimated annual financial impact of gene therapy in the United States","volume":"30","author":"Wong","year":"2023","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtn.2025.102788_bib67","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.exer.2009.02.009","article-title":"Retinal pathway origins of the pattern ERG of the mouse","volume":"89","author":"Miura","year":"2009","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.omtn.2025.102788_bib68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1017\/S0952523805225166","article-title":"Independent visual threshold measurements in the two eyes of freely moving rats and mice using a virtual-reality optokinetic system","volume":"22","author":"Douglas","year":"2005","journal-title":"Vis Neurosci."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003427?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253125003427?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:19:50Z","timestamp":1780103990000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253125003427"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2162253125003427"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102788","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"AAV2-mediated intravitreal delivery of exon-specific U1 snRNA rescues optic neuropathy in familial dysautonomia","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2025.102788","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102788"}}